STAT

STAT

Share

STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We dissect crucial discoveries.

We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress 09/26/2026

News: Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress

Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.

Federal judge rolls back landmark disability protections 09/25/2026

https://trib.al/6N1Mojz

Federal judge rolls back landmark disability protections The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and receiving services in their communities, rather than in nursing homes or facilities. It is making good on that promise.

FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug 09/25/2026

“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.

FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug “With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.

09/25/2026

“The epidemiology and genetics of heart attack and stroke risk, for now, seem to have outpaced what more we can actually do about it."

Up and down the ladder: The latest comings and goings 09/25/2026

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic 09/25/2026

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals with 11 manufacturers to develop and manufacture generic versions of a Roche influenza treatment.

Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

Lilly wins approval for once-weekly insulin shot 09/25/2026

https://trib.al/pUR3YGU

Lilly wins approval for once-weekly insulin shot The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.

Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic 09/25/2026

With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.

RFK Jr.’s use of the National Center for Health Statistics will add confusion to measles deaths count 09/25/2026

“A discrepancy between how federal and state public health officials determine measles deaths will only increase public confusion,” write Denys T. Lau and Jennifer D. Schoendorf.

RFK Jr.’s use of the National Center for Health Statistics will add confusion to measles deaths count “A discrepancy between how federal and state public health officials determine measles deaths will only increase public confusion,” write Denys T. Lau and Jennifer D. Schoendorf.

At least five candidates vie to become the next WHO leader, as questions over U.S. role loom 09/25/2026

At least five candidates are in the running to become the next director-general of the World Health Organization, a job that will come with extraordinary challenges.

At least five candidates vie to become the next WHO leader, as questions over U.S. role loom At least five candidates are in the running to become the next director-general of the WHO, a job that will come with extraordinary challenges.

Want your business to be the top-listed Media Company in Boston?
Click here to claim your Sponsored Listing.

Address


1 Exchange Place
Boston, MA
02120

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm